Vaccine rate forecast for COVID-19 in Africa using hybrid forecasting models

被引:1
|
作者
Dhamodharavadhani, S. [1 ]
Rathipriya, R. [1 ]
机构
[1] Periyar Univ, Dept Comp Sci, Salem, India
关键词
Gaussian Regression Process; Hybrid GRNN; TIME-SERIES; SURVEILLANCE; SYSTEM; INDIA;
D O I
10.4314/ahs.v23i1.11
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The public health sectors can use the forecasting applications to determine vaccine stock requirements to avoid excess or shortage stock. This prediction will ensure that immunization protection for COVID- 19 is well-distributed among Objective: The aim of this study is to forecast vaccination rate for COVID-19 in Africa Methods: The method used to estimate predictions is the hybrid forecasting models which predicts the COVID-19 vaccination rate (CVR). HARIMA is a hybrid of ARIMA and the Linear Regression model and HGRNN is a hybrid of Generalized Regression Neural Network (GRNN) and the Gaussian Process Regression (GPR) model which are used to improve predictive Results: In this study, standard and hybrid forecasting models are used to evaluate new COVID-19 vaccine cases daily in May and June 2021. To evaluate the effectiveness of the models, the COVID-19 vaccine dataset for Africa was used, which included are used as evaluation measures in this process. The results obtained showed that the hybrid GRNN model performed better Conclusion: HGRNN model provides accurate daily vaccinated case forecast, which helps to maintain optimal vaccine stock to avoid vaccine wastage and save many lives. Keywords: Vaccination forecasting; ARIMA; Immunization; Time series techniques; Hybrid ARIMA; Prediction; Linear Regression;
引用
收藏
页码:93 / 103
页数:11
相关论文
共 50 条
  • [21] COVID-19 vaccine wastage in Africa: A case of Nigeria
    Musa, Muhammad Kabir
    Abdulsalam, Abdullateef
    Haruna, Usman Abubakar
    Zakariya, Farida
    Salisu, Sanusi Muhammad
    Onajin-Obembe, Bisola
    Idris, Suleman Hadejia
    Lucero-Prisno III, Don Eliseo
    INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2024, 39 (02): : 229 - 236
  • [22] COVID-19 Africa builds mRNA vaccine capacity
    Servick, Kelly
    SCIENCE, 2022, 375 (6583) : 798 - 798
  • [23] Testing the Accuracy of the ARIMA Models in Forecasting the Spreading of COVID-19 and the Associated Mortality Rate
    Ilie, Ovidiu-Dumitru
    Ciobica, Alin
    Doroftei, Bogdan
    MEDICINA-LITHUANIA, 2020, 56 (11): : 1 - 23
  • [24] Forecasting COVID-19 Pandemic Using Prophet, ARIMA, and Hybrid Stacked LSTM-GRU Models in India
    Sah, Sweeti
    Surendiran, B.
    Dhanalakshmi, R.
    Mohanty, Sachi Nandan
    Alenezi, Fayadh
    Polat, Kemal
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [25] COVID-19: Vaccine Hesitancy in Africa and the way Forward
    Omeiza, Lukman Ahmed
    Azad, Abul Kalam
    Kozak, Kateryna
    Mafo, Abaniwo Rose
    Mamudu, Ukashat
    Daniel, Aikhonmu Oseyemen Daniel
    PROBLEMY EKOROZWOJU, 2022, 17 (02): : 39 - 46
  • [26] COVID-19 vaccine hesitancy in Africa: a scoping review
    Ackah, Betty B. B.
    Woo, Michael
    Stallwood, Lisa
    Fazal, Zahra A.
    Okpani, Arnold
    Ukah, Ugochinyere Vivian
    Adu, Prince A.
    GLOBAL HEALTH RESEARCH AND POLICY, 2022, 7 (01)
  • [27] COVID-19 vaccine hesitancy in Africa: a call to action
    Mutombo, Polydor Ngoy
    Fallah, Mosoka P.
    Munodawafa, Davison
    Kabel, Ahmed
    Houeto, David
    Goronga, Tinashe
    Mweemba, Oliver
    Balance, Gladys
    Onya, Hans
    Kamba, Roger S.
    Chipimo, Miriam
    Kayembe, Jean-Marie Ntumba
    Akanmori, Bartholomew
    LANCET GLOBAL HEALTH, 2022, 10 (03): : E320 - E321
  • [28] Safety and efficiency of COVID-19 vaccine in North Africa
    Chelly, Souhir
    Jaziri, Shayma
    Ammar, Asma
    Ezzi, Olfa
    Douss, Nour
    Saffar, Sonia
    Tritar, Marouen
    Njah, Mansour
    Mahjoub, Mohamed
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [29] COVID-19 vaccine hesitancy in Africa: a scoping review
    Betty B. B. Ackah
    Michael Woo
    Lisa Stallwood
    Zahra A. Fazal
    Arnold Okpani
    Ugochinyere Vivian Ukah
    Prince A. Adu
    Global Health Research and Policy, 7
  • [30] Access considerations for a COVID-19 vaccine for South Africa
    Bangalee, Varsha
    Suleman, Fatima
    SOUTH AFRICAN FAMILY PRACTICE, 2020, 62 (01) : 1 - 4